Norges Bank’s Amylyx Pharmaceuticals AMLX Stock Holding History

Norges Bank’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.87M	Buy	+159,900	New	+$2.47M	﹤0.01%	1452
2024 Q1	–	Sell	-116,400	Closed	-$1.71M	–	1890
2023 Q4	$1.71M	Buy	+116,400	New	+$1.78M	﹤0.01%	1806
2023 Q3	–	Sell	-84,100	Closed	-$1.81M	–	1969
2023 Q2	$1.81M	Sell	84,100 -7,800	-8%	-$211K	﹤0.01%	1880
2023 Q1	$2.7M	Buy	91,900 +10,700	+13%	+$372K	﹤0.01%	1883
2022 Q4	$3M	Buy	+81,200	New	+$2.88M	﹤0.01%	1906

Other funds holding AMLX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Jupiter Topco New York $245B AUM

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Norges Bank's AMLX Position: Q2 2026 in Review

Norges Bank opened a new position in Amylyx Pharmaceuticals (AMLX) in Q2 2026: 159,900 shares worth $2.87M. The stake represents ﹤0.01% of the portfolio and ranks #1452 among its holdings. This is a return to the name: Norges Bank previously reported a position in AMLX as recently as Q4 2023.

Norges Bank first reported a position in AMLX in Q4 2022 and has held it in 5 quarters since. The position peaked at $3M in Q4 2022. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

Norges Bank held 159,900 shares of Amylyx Pharmaceuticals worth $2.87M as of Q2 2026.
Amylyx Pharmaceuticals was a new Norges Bank position in Q2 2026.
Amylyx Pharmaceuticals made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1452 holding.
Norges Bank first reported a position in Amylyx Pharmaceuticals in Q4 2022 and has held it in 5 quarters since.
Norges Bank's Amylyx Pharmaceuticals position peaked at $3M in Q4 2022.
206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.